在NSCLC中腺通路和免疫检查点双重阻塞的景观:基础研究和临床应用的进展
Rulan Wang1,2, Zhenkun Liu1,2, Ting Wang1,2
1Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in immunology
|February 13, 2024
概括
向腺路径可以克服肺癌中的免疫抵抗. 将腺途径抑制剂与免疫检查点阻断剂结合起来,有望改善肺癌患者的免疫疗法疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像化疗这样的肺癌治疗方法的疗效有限.
- 免疫疗法提供持续缓解,但面临免疫抵抗.
- 腺路径有助于免疫抑制瘤微环境,阻碍免疫治疗反应.
研究的目的:
- 审查腺在肺癌免疫抑制中的作用.
- 讨论用于逆转免疫抵抗的腺酶通路抑制剂.
- 突出结合腺抑制剂和肺癌免疫检查点阻断剂的双重阻断策略.
主要方法:
- 临床前和临床研究的文献综述.
- 对肺癌中腺路径机制的分析.
- 评估腺抑制剂和免疫检查点阻断剂组合疗法.
主要成果:
- 腺素途径显著促进肺瘤诱导的免疫抑制.
- 腺胺抑制剂显示出逆转这种免疫抑制的潜力.
- 组合疗法在临床前和临床环境中显示出增强抗瘤免疫力的前景.
结论:
- 腺路径是克服肺癌免疫抵抗的关键目标.
- 腺和免疫检查点的双重阻断是一种有前途的治疗策略.
- 需要进一步进行临床研究,以优化肺癌患者的组合疗法.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


